CO1686 - 3rd Generation Drug for Acquired Resistance in EGFR Lung Cancer
Jun 29, 2014 ·
4m 9s
Lung cancer patients with the EGFR mutation who had progressed on other drugs did well on a new drug in clinical trial, though one particular side effect concerns some.
Information
| Author | cancerGRACE |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
